{"id":48523,"date":"2017-09-20T13:44:45","date_gmt":"2017-09-20T13:44:45","guid":{"rendered":"https:\/\/mppt.hu\/project\/2017-szeptember-xix-evfolyam-3-szam\/"},"modified":"2020-10-19T19:57:32","modified_gmt":"2020-10-19T19:57:32","slug":"2017-szeptember-xix-evfolyam-3-szam","status":"publish","type":"project","link":"https:\/\/mppt.hu\/en\/project\/2017-szeptember-xix-evfolyam-3-szam\/","title":{"rendered":"Volume 19, Issue 4, September 2017"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;3.22.7&#8243; custom_padding=&#8221;||6px|||&#8221;][et_pb_row _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;||17px|||&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;3.27.4&#8243;]<\/p>\n<h4 style=\"text-align: center;\">Volume 19, Issue 4, September 2017<\/h4>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.22.3&#8243; custom_padding=&#8221;24px|0px|25px|0px|false|false&#8221;][et_pb_column type=&#8221;3_4&#8243; specialty_columns=&#8221;3&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.25&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;3_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;In memoriam&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/nekrolog_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;3.22.7&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/nekrolog_honlapra.pdf&#8221; link_option_url_new_window=&#8221;on&#8221;]<\/p>\n<p><strong>V\u00e9gs\u0151 b\u00facs\u00fa Gaszner P\u00e9tert\u0151l<\/strong> &#8211; Faludi G\u00e1bor<\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract &#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;3.22.7&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]<\/p>\n<h4 class=\"art\">V\u00e9gs\u0151 b\u00facs\u00fa Gaszner P\u00e9tert\u0151l<\/h4>\n<div class=\"autors\">\n<p>Faludi G\u00e1bor<\/p>\n<\/div>\n<hr class=\"system-readmore\" \/>\n<div class=\"artbody\">\n<p>Kedves P\u00e9ter!<\/p>\n<p>Nehezen elmondhat\u00f3 megrendu\u0308lts\u00e9get \u00e9rzek, ahogy itt \u00e1llunk gy\u00e1szol\u00f3 csal\u00e1dod, bar\u00e1taid, koll\u00e9g\u00e1id,tisztel\u0151id k\u00f6r\u00e9ben, hogy elb\u00facs\u00fazzunk T\u0151led. A v\u00e9gs\u0151 elk\u00f6sz\u00f6n\u00e9s, az eml\u00e9kez\u00e9s, a tiszteletad\u00e1s alkalm\u00e1b\u00f3l megk\u00eds\u00e9relju\u0308k \u00f6sszegezni, hogy mit jelentett\u00e9l \u00e9s jelentesz neku\u0308nk, t\u00e1voz\u00e1soddal kit vesz\u00edtettu\u0308nk el, mit \u0151rzu\u0308nk \u00e9s mit viszu\u0308nk tov\u00e1bb tan\u00edt\u00e1saidb\u00f3l, mi\u00e9rt szerettu\u0308nk \u00e9s tiszteltu\u0308nk, \u00e9s mi\u00e9rt fogunk R\u00e1d mindig eml\u00e9kezni.<\/p>\n<\/div>\n<p>[\/et_pb_toggle][et_pb_blurb title=&#8221;In Memoriam Peter Gaszner (1939\u20132017)&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/interview_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;3.22.7&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/interview_honlapra.pdf&#8221; link_option_url_new_window=&#8221;on&#8221;]<\/p>\n<p>Thomas A. Ban and Andrea Tone<\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract &#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;3.22.7&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]<\/p>\n<p>On July 25, 2017, Peter Gaszner, a close friend and a member of our International Network for the History of Neuropsychopharmacology, passed away.<\/p>\n<p>Peter Gaszner was born in 1939, in Bekescsaba, Hungary. He received his MD from the University of Debrecen, Hungary, in 1963, and earned diplomas in neurology, psychiatry and clinical pharmacology in 1957, 1970 and 1980, respectively. He was trained in psychiatry in the Department of Psychiatry at the University of Pecs. During the 1980s, Dr. Gaszner became Director of Psychopharmacology at the National Institute of Neurology and Psychiatry of Hungary and Professor of Psychiatry at Semmelweis University and during the 1990s, he served as Vice President of the European College of Neuropsychopharmacology. Dr. Gaszner was Founding President of the Hungarian Psychopharmacology Society and Founding Editorin-Chief of Neuropsychopharmacologia Hungarica, the journal of the society (Salzman 2011).<\/p>\n<p>All through his professional career Peter was involved in research. In the 1970s his research interest was focused on atropine coma therapy and on epilepsy and anticonvulsants (Ban 2011; Faludi and Ban 2001). In a series of studies conducted in the early 1980s in normal subjects, in collaboration with Elemer Szabadi and Christopher Bradshaw, he demonstrated differences in peripheral anticholinergic activity among tricyclic antidepressants. They had also shown adrenergic blocking effect with neuroleptics (Gaszner, Szabadi and Bradshaw 1980; Szabadi, Gaszner and Bradshaw 1980, 1981). In the 1990s, Dr. Gaszner was a member of the international team which demonstrated the efficacy of reboxetine in major depression (Ban, Gaszner, Aguglia, et al 1998). At the time he was Visiting Professor in our Division of Psychopharmacology at Vanderbilt University, in Nashville we collaborated in developing a Composite Diagnostic Evaluation of Hyperthymic Disorders to study the therapeutic profile of drugs used in the treatment of mania (Gaszner and Ban 1998).<\/p>\n<p>On December 15, 2004, Peter Gaszner (PG) was interviewed by Andrea Tone (AT) at the annual meeting of the American College of Neuropsychopharmacology (ACNP) in San Juan, Puerto Rico. His edited interview (see below) was first printed in volume 8 of ACNP\u2019s Oral History Series (Ban 2011; Salzman 2011).<\/p>\n<p>[\/et_pb_toggle][et_pb_blurb title=&#8221;Assessing suicide risk based on a hierarchical classification of risk factors&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/rihmer_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.6&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/rihmer_honlapra.pdf&#8221;]<\/p>\n<p>Zolt\u00e1n Rihmer, P\u00e9ter D\u00f6me, X\u00e9nia Gonda, and Zsuzsanna\u00a0 \u00a0B\u00e9lteczki\u00a0<\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract &#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;3.22.7&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]<\/p>\n<p>Suicide risk factors could be organised into a hierarchical order and a questionnaire constructed<br \/>based on this hierarchical structure may help clinicians assess suicide risk. The paper presents<br \/>analysis of the clinical utility of a questionnaire developed by the authors, in samples of suicidal and nonsuicidal psychiatric patients as well as among normal control subjects. Based<br \/>on their results the authors suggest a shorter and expectedly more sensitive, 6-item version<br \/>instead of the original 12-item version scale.<\/p>\n<p>Keywords: suicide, suicide attempt, suicide risk factors, hierarchical classification, sensitivity<\/p>\n<p>[\/et_pb_toggle][et_pb_blurb title=&#8221;The importance of anxiety and depression in family practice&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/torzsa_honlapra2.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.6&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/torzsa_honlapra2.pdf&#8221;]<\/p>\n<p>P\u00e9ter Torzsa, Csenge\u00a0 Hargittay and L\u00e1szl\u00f3 Kalabay<\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract &#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;3.22.7&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]<\/p>\n<p class=\"art\">Representative studies indicate that prevalence of anxiety disorders among adults is between<br \/>12.6-17.2%, while in Hungary it is 17.7%. According to both international and national studies<br \/>the point prevalence of diagnosed major depression requiring treatment is 6-10 % in general<br \/>practice. As untreated depression is the most important risk factor for suicide, early detection<br \/>and effective management of depression are critical in prevention. According to international and national studies the recognition of major depression in primary care significantly<br \/>contributes to the decline of suicide mortality. In our article we review screening of anxiety<br \/>and depressive disorders and treatment and management of these patients in primary care.<br \/>We present two short questionnaires used for recognizing depression and acute suicide risk<br \/>and describe their use in family\/ general practice.<\/p>\n<p class=\"art\">Keywords: anxiety, depression, suicide, screening, general practitioner<\/p>\n<p>[\/et_pb_toggle][et_pb_blurb title=&#8221;Psychiatric disorders in epilepsy: clinical phenomena&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/szucs_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.6&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/szucs_honlapra.pdf&#8221;]<\/p>\n<p>Anna Sz\u0171cs, Andr\u00e1s Horv\u00e1th, D\u00e1niel Fab\u00f3, G\u00e9za Szab\u00f3, Andrea Kov\u00e1cs and P\u00e9ter Hal\u00e1sz<\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract &#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;3.22.7&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]<\/p>\n<p>The frequent psychiatric comorbidity in epilepsy compromises the quality of life of those<br \/>affected, further increasing their suicide risk and the high burden of stigmatisation. Out of<br \/>adulthood epilepsies, mesio-temporal lobe epilepsy carries the highest cognitive and psychiatric risk, making mental health comorbidities its inherent features. The pathomechanism<br \/>of the epilepsy-related mental health symptoms and conditions appears to be related to<br \/>undetected subclinical seizures, postictal exhaustion and inhibition, and the non-REM sleep<br \/>related interictal epileptic activity. In our work we try to present some of the typical psychiatric<br \/>syndromes and conditions seen in epilepsy. We aim to highlight the difficulties of treatment<br \/>on the borderline of neurology and psychiatry.<\/p>\n<p>Keywords: epilepsy, neuropsychiatry, comorbidity, psychiatric disorders<\/p>\n<p>[\/et_pb_toggle][et_pb_blurb title=&#8221;New aspects in the pathomechanism of diseases of civilization, particularly psychosomatic disorders. Part 2. Chronic hypocapnia and hypercapnia in the medical practice&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/sikter_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.6&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/sikter_honlapra.pdf&#8221;]<\/p>\n<p>Andras Sikter, Zoltan Rihmer, and Roberto de Guevara<\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract &#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;3.22.7&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]<\/p>\n<h4 class=\"art\">New aspects in the pathomechanism of diseases of civilization, particularly psychosomatic disorders. Part 2. Chronic hypocapnia and hypercapnia in the medical practice<\/h4>\n<div class=\"autors\">\n<p>Andras Sikter<sup>1<\/sup>, Zoltan Rihmer<sup>2,3<\/sup>\u00a0and Roberto de Guevara<sup>4<\/sup><\/p>\n<hr id=\"system-readmore\" \/>\n<p><em><sup>1<\/sup>\u00a0Municipal Clinic of Szentendre, Internal Medicine, Szentendre, Hungary<\/em><\/p>\n<p><em><sup>2\u00a0<\/sup>Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary<\/em><\/p>\n<p><em><sup>3<\/sup>\u00a0National Institute of Psychiatry and Addictions, Laboratory for Suicide Research and Prevention, Budapest, Hungary<\/em><\/p>\n<p><em><sup>4<\/sup>\u00a0Respiras-performance breathing, Colorado Springs, United States of America<\/em><\/p>\n<\/div>\n<hr class=\"system-readmore\" \/>\n<div class=\"artbody\">\n<p>The authors seek to find new connections between recent results of biology and older theories. This paper aims to assemble the jigsaw puzzle. The theoretical background of the hypothesis was described in the previous issue of the journal (Sikter et al. 2017a). Human stress response often coexists with persistent hypocapnia or hypercapnia \u2013 developing via psychosomatic pathomechanism \u2013 which can lead to mental and psychosomatic illnesses. Chronic hypocapnia mainly generates hyperarousal disorders which may be reversible for an extended time, however, vicious cycles may start when hypoxia and\/or severe somatic diseases are simultaneously present (commonly in the elderly), which conditions often end with death without medical help. Chronic hypercapnia devastates the organism initially without symptoms, partly due to neurohumoral contraregulation, consequential dysregulation and metabolic remodeling. Psychosomatic disorders (e.g., diseases of civilization that evolve in people with disadvantaged psychosocial situations) develop over years and decades, causing irreversible changes. Hypercapnia usually occurs in clinical pictures of chronic obstructive pulmonary disease, obesity hypoventilation syndrome, obstructive sleep apnea, and its unobstructed version (sleep-related hypoventilation), generating various organic disorders (hypertension, type 2 diabetes, cardiovascular disorders, immunological diseases, depression, etc.). Because of the above, chronic hypocapnia and hypercapnia cannot be regarded as harmless accompanying\u00a0phenomena. That is why we have to strive for restoring eucapnia and normalizing the induced ionic changes, which does not appear to be a hopeless task.<\/p>\n<p><em>(Neuropsychopharmacol Hung 2017; 19(3): 159\u2013169)<\/em><\/p>\n<p><strong>Keywords:\u00a0<\/strong>depression as an extreme hypoarousal, diseases of civilization, idea of restoring the milieu int\u00e9rieur, remodeling of metabolism<\/p>\n<\/div>\n<p>[\/et_pb_toggle][et_pb_blurb title=&#8221;Foly\u00f3irat-refer\u00e1tumok&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/folyoiratref_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.6&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xix-evfolyam-3-szam\/folyoiratref_honlapra.pdf&#8221;]<\/p>\n<p>P\u00e9ter L\u00e1szl\u00f3; M\u00f3ra Bal\u00e1zs<\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract &#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;3.22.7&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]<\/p>\n<h4 class=\"art\">Foly\u00f3irat-refer\u00e1tumok<\/h4>\n<div class=\"autors\">\n<p>P\u00e9ter L\u00e1szl\u00f3; M\u00f3ra Bal\u00e1zs<\/p>\n<\/div>\n<hr class=\"system-readmore\" \/>\n<div class=\"artbody\">\n<p><strong>A relapszus kock\u00e1zata az antidepressz\u00edv ter\u00e1pia elhagy\u00e1s\u00e1t k\u00f6vet\u0151en szorong\u00e1sos betegs\u00e9gekben, k\u00e9nyszerbetegs\u00e9gben \u00e9s poszt-traum\u00e1s stressz betegs\u00e9gben<\/strong><br \/>Risk of Relapse After Antidepressant Discontinuation in Anxiety Disorders, Obsessive-compulsive Disorder, and Post-traumatic Stress Disorder; Systematic Review and Meta-analysis of Relapse Prevention Trials; Neeltje M Batelaan, Renske Bosman, Anna Muntingh, Willemijn D Scholten, Klaas M Huijbregts, Anton J L M an Balkom; BMJ, 2017; 358 (j3927)<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Az alkohol okozta dependencia farmakoter\u00e1pi\u00e1ja\u00a0<br \/><\/strong>Pharmacotherapy for alcohol dependence \u2013 the why, the what and the wherefore; E. T. Goh, M. Y. Morgan; Alimentary Pharmacology &amp; Therapeutics. 2017;45(7):865-882<\/p>\n<\/div>\n<p>[\/et_pb_toggle][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/05\/b1_2017_szept_honlapra_kicsi.jpg&#8221; align_tablet=&#8221;center&#8221; align_phone=&#8221;&#8221; align_last_edited=&#8221;on|desktop&#8221; _builder_version=&#8221;3.23&#8243; box_shadow_style=&#8221;preset3&#8243;][\/et_pb_image][\/et_pb_column][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Volume 19, Issue 4, September 2017V\u00e9gs\u0151 b\u00facs\u00fa Gaszner P\u00e9tert\u0151l &#8211; Faludi G\u00e1borV\u00e9gs\u0151 b\u00facs\u00fa Gaszner P\u00e9tert\u0151l Faludi G\u00e1bor Kedves P\u00e9ter! Nehezen elmondhat\u00f3 megrendu\u0308lts\u00e9get \u00e9rzek, ahogy itt \u00e1llunk gy\u00e1szol\u00f3 csal\u00e1dod, bar\u00e1taid, koll\u00e9g\u00e1id,tisztel\u0151id k\u00f6r\u00e9ben, hogy elb\u00facs\u00fazzunk T\u0151led. A v\u00e9gs\u0151 elk\u00f6sz\u00f6n\u00e9s, az eml\u00e9kez\u00e9s, a tiszteletad\u00e1s alkalm\u00e1b\u00f3l megk\u00eds\u00e9relju\u0308k \u00f6sszegezni, hogy mit jelentett\u00e9l \u00e9s jelentesz neku\u0308nk, t\u00e1voz\u00e1soddal kit vesz\u00edtettu\u0308nk el, mit [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":48297,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"project_category":[58],"project_tag":[],"class_list":["post-48523","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-neuropsychopharmacologia-hungarica-3-en"],"_links":{"self":[{"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project\/48523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/comments?post=48523"}],"version-history":[{"count":14,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project\/48523\/revisions"}],"predecessor-version":[{"id":49487,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project\/48523\/revisions\/49487"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/media\/48297"}],"wp:attachment":[{"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/media?parent=48523"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project_category?post=48523"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project_tag?post=48523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}